IMPACT OF SWITCHING TO NEW ANTIDIABETIC MEDICATIONS ON UTILIZATION AND COSTS

被引：0
|
作者：
Munshi, K. [1 ]
Neilson, L. [2 ]
Good, C. [3 ]
Huang, Y. [2 ]
Henderson, R. [4 ]
Parekh, N. [5 ]
机构：
[1] Express Scripts Holding Co, Memphis, TN USA
[2] UPMC Ctr High Value Hlth Care, Pittsburgh, PA USA
[3] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA
[4] Express Scripts, St Louis, MO USA
[5] UPMC, Insurance Serv Div, Pittsburgh, PA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB82
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 50 条
  • [21] Management of antidiabetic medications in overdose
    Spiller, HA
    DRUG SAFETY, 1998, 19 (05) : 411 - 424
  • [22] Management of Antidiabetic Medications in Overdose
    Henry A. Spiller
    Drug Safety, 1998, 19 : 411 - 424
  • [23] Compliance to antihypertensive and antidiabetic medications
    Gypens, J.
    Wirth, F.
    Azzopardi, L. M.
    Steurbaut, S.
    Fava, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1347 - 1348
  • [24] Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study
    Miyachi, Hideaki
    Sato, Daisuke
    Sakamaki, Kentaro
    Togawa, Yaei
    Yoshimura, Kensuke
    JOURNAL OF DERMATOLOGY, 2024, 51 (09): : 1172 - 1179
  • [25] Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
    Cotter, Gad
    Davison, Beth A.
    Edwards, Christopher
    Senger, Stefanie
    Teerlink, John R.
    Zannad, Faiez
    Nielsen, Olav Wendelboe
    Metra, Marco
    Mebazaa, Alexandre
    Chioncel, Ovidiu
    Greenberg, Barry H.
    Maggioni, Aldo P.
    Ertl, Georg
    Sato, Naoki
    Cohen-Solal, Alain
    AMERICAN HEART JOURNAL, 2021, 240 : 73 - 80
  • [26] The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression
    Xing, Shan
    Calip, Gregory S.
    Leow, Alex D.
    Kim, Shiyun
    Schumock, Glen T.
    Touchette, Daniel R.
    Lee, Todd A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (05) : 492 - 500
  • [27] The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview
    Zarei, Malek
    Vaighan, Navideh Sahebi
    Shiravand, Sepideh
    Mohammadvali-samani, Sara
    Sheikholeslami, Mohammad Abbas
    Roudbari, Zahra
    PHYSIOLOGY AND PHARMACOLOGY, 2024, 28 (04): : 363 - 388
  • [28] The Impact of Adherence to Antidiabetic Medications on Glycaemic Control in Type 2 Diabetes Patients
    Wright, Alison K.
    Ashcroft, Darren M.
    Rutter, Martin K.
    Emsley, Richard
    Steinke, Douglas T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 505 - 505
  • [29] Utilization and Costs of Cardiovascular Disease Medications in Dialysis Patients in Medicare Part D
    Frankenfield, Diane L.
    Weinhandl, Eric D.
    Powers, Christopher A.
    Howell, Benjamin L.
    Herzog, Charles A.
    St Peter, Wendy L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (05) : 670 - 681
  • [30] Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
    McPherson, Timothy
    Fontane, Patrick
    Iyengar, Reethi
    Henderson, Rochelle
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (02): : 172 - 181
12345